Determinants of Bladder Cancer Recurrence Study (The DETER Study)

Memorial Sloan Kettering Cancer Center (MSK)

Status: Active, not recruiting

Conditions: Bladder Cancer

Treatments: Other: Saliva and/or urine sample; Behavioral: questionnaires

Study type: Observational

Funder types: Other

Identifiers

NCT02400944

15-047

Details and patient eligibility

About

The purpose of this study is to learn how different lifestyle factors, such as cigarette smoking and body weight, change after a diagnosis of bladder cancer, and how they influence who gets a bladder cancer recurrence and who does not.

Enrollment: 600 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients ≥18 years old AND
• Histologically-confirmed non-muscle invasive bladder cancer (NMIBC)

Exclusion criteria

• Patients are ineligible for the study if they have/had:
• Histologically-confirmed NMIBC diagnosed >36 months prior to enrollment
• Cystectomy prior to enrollment
• Any condition, which in the opinion of the primary MSK clinician or investigators precludes their ability to provide informed consent or comply with study procedures
• Non English-speaking

Trial design

600 participants in 1 patient group

patients with bladder cancer

Treatment:

Behavioral: questionnaires

Other: Saliva and/or urine sample